Skip to main content

Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.

Szpechcinski A, Struniawska R, Zaleska J, Chabowski M, Orlowski T, Roszkowski K, Chorostowska-Wynimko J

Publication: J Physiol Pharmacol (2008) • Vol 59 Suppl 6 • Page 675-81PMID: 19218694View on PubMed

Purpose

The purpose of this paper was to compare DNA quantification methods and determine the effect of treatment and surgery on plasma DNA levels.

Conclusion

Mean DNA concentrations, were higher when determined using PicoGreen than those determined by TaqMan and SYBR real-time PCR. However, DNA concentrations determined by the three methods were strongly or very strongly correlated. The authors report that plasma DNA levels for 7 of the 10 patients examined differed significantly among those obtained before treatment, after neoadjuvant therapy and after surgery.

Studies (1)

Purpose

The purpose of this study was to compare DNA quantification by PicoGreen fluorometry, TaqMan real-time PCR, and SYBR real-time PCR, and to determine the effect of treatment and surgery on plasma DNA levels. Blood was obtained from 10 non-small cell lung cancer (NSCLC) patients before treatment, after neoadjuvant therapy and after surgery. Plasma was obtained by centrifugation and stored frozen at -80ºC until DNA extraction using the QIAamp DNA Blood Midi kit. DNA was stored at -20ºC until quantification with PicoGreen and by real-time PCR amplification of β-Actin using SYBR and TaqMan chemistries.

Summary of Findings

Mean DNA concentrations were 5-fold higher when determined using PicoGreen than by TaqMan real-time PCR, and 10-fold higher than by SYBR real-time PCR (p<0.03). However, concentrations determined via the PicoGreen method were strongly correlated with those determined by SYBR green real-time PCR (r=0.87, p<0.0001) and very strongly correlated with those determined by TaqMan real-time PCR (r=0.94, p<0.0001). Further, concentrations determined by real-time PCR using SYBR and TaqMan were very strongly correlated (r=0.96, p<0.0001). The authors report that plasma DNA levels for 7 of the 10 patients examined differed significantly among those obtained before treatment, after neoadjuvant therapy and after surgery.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAFluorometry
    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionTime of biospecimen collection
    After neoadjuvant therapy
    After surgery
    Before treatment
    Real-time qPCR SpecificDetection method
    SYBR green
    TaqMan
    Real-time qPCR SpecificTechnology platform
    PicoGreen fluoremetry
    SYBR green
    TaqMan probes